Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben Hermann

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 11, 2023
Training spatial hearing in unilateral cochlear implant users through reaching to sounds in virtual realityChiara Valzolgher, Sabrina Bouzaid, Solene Grenouillet, et al.
Journal of Clinical Medicine|May 3, 2020
Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter TrialSophie Dupuis-Girod, Anne-Emmanuelle Fargeton, Vincent Grobost, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 17, 2018
Association of the Duration of Antibiotic Therapy With Major Surgical Site Infection in Cochlear ImplantationAchraf Sayed-Hassan, Ruben Hermann, Frédéric Chidiac, et al.
European Journal of Medical Genetics|August 8, 2022
European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?Sophie Dupuis-Girod, Claire L Shovlin, Anette D Kjeldsen, et al.
Angiogenesis|December 24, 2024
Effect of oral nintedanib vs placebo on epistaxis in hereditary hemorrhagic telangiectasia: the EPICURE multicenter randomized double-blind trialRuben Hermann, Vincent Grobost, Xavier Le-Guillou, et al.
Journal of Internal Medicine|August 18, 2023
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trialSophie Dupuis-Girod, Sophie Rivière, Christian Lavigne, et al.
Journal of Clinical Medicine|June 11, 2020
Speech Perception Changes in the Acoustically Aided, Nonimplanted Ear after Cochlear Implantation: A Multicenter StudyMario A Svirsky, Arlene C Neuman, Jonathan D Neukam, et al.
Vaccine|July 27, 2024
A quick access to information on influenza burden and prevention in Lyon university hospital: A prospective QR code-based information campaign in 2022-2023Nagham Khanafer, Sylvain Oudot, Margot Maligeay, et al.
Life (Basel, Switzerland)|March 28, 2024
The Prognostic Value of Olfactory Dysfunction in Patients with COVID-19: The COVIDORA StudyAnne-Laure Hamel, Léo Delbos, Pierre-André Natella, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 11, 2023
Training spatial hearing in unilateral cochlear implant users through reaching to sounds in virtual realityChiara Valzolgher, Sabrina Bouzaid, Solene Grenouillet, et al.
Journal of Clinical Medicine|May 3, 2020
Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter TrialSophie Dupuis-Girod, Anne-Emmanuelle Fargeton, Vincent Grobost, et al.
JAMA Otolaryngology-- Head & Neck Surgery|October 17, 2018
Association of the Duration of Antibiotic Therapy With Major Surgical Site Infection in Cochlear ImplantationAchraf Sayed-Hassan, Ruben Hermann, Frédéric Chidiac, et al.
European Journal of Medical Genetics|August 8, 2022
European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?Sophie Dupuis-Girod, Claire L Shovlin, Anette D Kjeldsen, et al.
Angiogenesis|December 24, 2024
Effect of oral nintedanib vs placebo on epistaxis in hereditary hemorrhagic telangiectasia: the EPICURE multicenter randomized double-blind trialRuben Hermann, Vincent Grobost, Xavier Le-Guillou, et al.
Journal of Internal Medicine|August 18, 2023
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trialSophie Dupuis-Girod, Sophie Rivière, Christian Lavigne, et al.
Journal of Clinical Medicine|June 11, 2020
Speech Perception Changes in the Acoustically Aided, Nonimplanted Ear after Cochlear Implantation: A Multicenter StudyMario A Svirsky, Arlene C Neuman, Jonathan D Neukam, et al.
Vaccine|July 27, 2024
A quick access to information on influenza burden and prevention in Lyon university hospital: A prospective QR code-based information campaign in 2022-2023Nagham Khanafer, Sylvain Oudot, Margot Maligeay, et al.
Life (Basel, Switzerland)|March 28, 2024
The Prognostic Value of Olfactory Dysfunction in Patients with COVID-19: The COVIDORA StudyAnne-Laure Hamel, Léo Delbos, Pierre-André Natella, et al.
Pageof 4